Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea
M Unemo1, D Golparian, G Syversen
1Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Orebro University Hospital, Orebro, Sweden. magnus.unemo@orebroll.se
Abstract:
Neisseria gonorrhoeae has developed resistance to most of the available therapeutic antimicrobials. The susceptibility to extended-spectrum cephalosporins, the last remaining first-line treatment option, is decreasing globally. This report describes the first two cases outside Japan of verified gonorrhoea clinical failures using internationally recommended first-line cefixime treatment. Enhanced awareness and more frequent follow-up examination, test-of-cure and appropriate verification/falsification of presumed clinical treatment failures, involving several clinical and laboratory parameters should be strongly emphasised worldwide.
More Related Videos
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Urine Studies II: Urine Culture and Sensitivity Test
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management


